Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Free Cash Flow (2020 - 2025)

LifeStance Health (LFST) has disclosed Free Cash Flow for 6 consecutive years, with $46.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 16.72% to $46.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $110.0 million, a 28.39% increase, with the full-year FY2025 number at $110.0 million, up 28.39% from a year prior.
  • Free Cash Flow was $46.6 million for Q4 2025 at LifeStance Health, up from $17.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $56.6 million in Q2 2025 to a low of -$35.2 million in Q3 2023.
  • A 5-year average of $5.7 million and a median of -$4.6 million in 2021 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: tumbled 1999.15% in 2022, then skyrocketed 940.98% in 2024.
  • LifeStance Health's Free Cash Flow stood at -$8.0 million in 2021, then soared by 417.51% to $25.5 million in 2022, then crashed by 78.93% to $5.4 million in 2023, then surged by 940.98% to $56.0 million in 2024, then dropped by 16.72% to $46.6 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Free Cash Flow are $46.6 million (Q4 2025), $17.0 million (Q3 2025), and $56.6 million (Q2 2025).